Drug Development

Clinical Trials Clinical Research Regulatory Affairs Therapeutics Regulatory Approval Weight-loss Drugs Pharmaceutical Research Oncology FDA Approval Biosimilars Biotechnology AI in Healthcare GLP-1 Drugs Alzheimer's Disease Alzheimer's Scientific Research Biologics Preclinical Research FDA Regulations Therapeutic Research Research Studies RNA-based Therapeutics Mifepristone Ruling Stelara Loss of Exclusivity Disease Treatment Pharmaceuticals Experimental Treatments Intellectual Property Injectable Medications Gene Therapy Research Applications Regulatory Framework Therapeutic Segments Tyrosine Kinase Inhibitors Phase 3 Trials Innovative Therapies Combination Therapy Therapeutic Targets Phase 2 Trials Efficacy Studies Drug Testing Breakthrough Therapy Designation Subcutaneous Administration Compounding Pharmacies Safety and Efficacy Bioequivalence Characterization Techniques Combination Therapies Obesity Treatments Molecular Studies Therapeutic Approaches Early Drug Discovery Preclinical Safety Testing

FIU to Host IonQ Superion 256 Quantum Computer on Miami Campus

Direct hardware access for students and researchers will anchor new research, education and workforce programs.

HHS Moves to Shift U.S. Biomedical Research From Animal Tests to Human-Based Methods

Alumis Shares Plunge After Phase 2b Lupus Trial Misses Primary Goal

Sandoz Signs Exclusive Deal to Commercialize Up to 10 Henlius Biosimilars

Pomerantz Files Securities Class Action Against Nektar Over REZOLVE‑AA Trial Disclosures

Clearmind’s AUD Candidate Meets Early Safety Goal as Shares Double

FDA Issues Second Rejection of Replimune’s RP1 Melanoma Therapy

Insmed Halts Brensocatib in Hidradenitis Suppurativa After Phase 2b Trial Fails

Priovant’s Brepocitinib Posts Strong Phase 2 Win in Cutaneous Sarcoidosis

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

Genmab Halts Acasunlimab to Focus on Late-Stage Cancer Portfolio

New iGluSnFR4 Sensor Lets Scientists See Neurons’ Incoming Signals in Living Brains

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion

BioCryst to Acquire Astria in $700 Million Cash-and-Stock Deal to Bolster HAE Portfolio

Moonlake Shares Plunge on Mixed Phase 3 Results for Hidradenitis Drug

Study Identifies Immune ‘Protein Battery’ That Speeds Defense but May Fuel Aging Inflammation

Johns Hopkins Researchers Grow Vascularized Whole-Brain Organoid With Network-Level Activity

Scientists Create Functional Blood Vessels and Liver Lobules on Microfluidic Chips